New study reveals how cancer drug repotrectinib interacts with common medicines
NCT ID NCT07223671
First seen Nov 03, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study looked at how a cancer drug called repotrectinib changes the way the body processes other medications. Thirty healthy adults took a mix of common drugs (like metformin and omeprazole) with and without repotrectinib to see if levels of those drugs changed. The goal was to understand potential drug interactions so doctors can prescribe repotrectinib more safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0001
Daytona Beach, Florida, 32117-5116, United States
Conditions
Explore the condition pages connected to this study.